GNAQ Mutation in the Venous Vascular Malformation and Underlying Brain Tissue in Sturge–Weber Syndrome

Abstract

The recent identification of the somatic GNAQ mutation (c.548G > A) provides insight into the pathogenesis of Sturge–Weber syndrome (SWS). Although the primary SWS brain pathology is the leptomeningeal angiomatosis (LMA), cerebral cortical and white matter abnormalities play a prominent role in the disease manifestations. In some cases, SWS brain involvement is present even without detectable LMA on magnetic resonance imaging (MRI). To expand our understanding of the etiology of SWS brain pathology, surgical SWS brain specimens from nine children (age: 0.8–7.5 years) were carefully separated into LMA and (non-LMA) brain tissue; the latter did not contain any vascular malformation. A custom Competitive Allele-Specific TaqMan PCR (castPCR) assay to detect the mutation in GNAQ was performed in these separated specimens. The mutation was present in all nine LMA and seven of the nine non-LMA brain tissues. LMA tissues were significantly enriched by the mutation, as compared with non-LMA brain (mean: 7.2 ± 2.1% and 1.2 ± 0.4%, respectively; p = 0.008). These results demonstrate that the somatic GNAQ mutation in SWS is not confined to the venous vascular malformation but can directly (although less severely) affect underlying brain parenchyma, not directly affected by LMA, and possibly contribute to SWS brain pathology. Future studies should identify the specific cell type(s) affected by the mutation in the SWS-affected brain parenchyma.

Keywords

Sturge–Weber syndrome - GNAQ mutation - brain tissue - epilepsy - surgery - leptomeningeal angiomatosis

• References

• 1 Bodensteiner JB, Roach ES. Overview of Sturge-Weber syndrome. In: Bodensteiner B, Roach ES. , eds. Sturge-Weber Syndrome. Mt Freedom, NJ: The Sturge-Weber Foundation; 2010: 19-32
• 2 Shirley MD, Tang H, Gallione CJ. , et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ . N Engl J Med 2013; 368 (21) 1971-1979
• 3 Comati A, Beck H, Halliday W, Snipes GJ, Plate KH, Acker T. Upregulation of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha in leptomeningeal vascular malformations of Sturge-Weber syndrome. J Neuropathol Exp Neurol 2007; 66 (01) 86-97
• 4 Juhász C, Haacke EM, Hu J. , et al. Multimodality imaging of cortical and white matter abnormalities in Sturge-Weber syndrome. AJNR Am J Neuroradiol 2007; 28 (05) 900-906
• 5 Pinto AL, Chen L, Friedman R. , et al. Sturge-Weber syndrome: brain magnetic resonance imaging and neuropathology findings. Pediatr Neurol 2016; 58: 25-30
• 6 Maton B, Krsek P, Jayakar P. , et al. Medically intractable epilepsy in Sturge-Weber syndrome is associated with cortical malformation: implications for surgical therapy. Epilepsia 2010; 51 (02) 257-267
• 7 Wang DD, Blümcke I, Coras R. , et al. Sturge-Weber syndrome is associated with cortical dysplasia ILAE Type IIIc and excessive hypertrophic pyramidal neurons in brain resections for intractable epilepsy. Brain Pathol 2015; 25 (03) 248-255
• 8 Couto JA, Huang L, Vivero MP. , et al. Endothelial cells from capillary malformations are enriched for somatic GNAQ mutations. Plast Reconstr Surg 2016; 137 (01) 77e-82e
• 9 Huang L, Couto JA, Pinto A. , et al. Somatic GNAQ mutation is enriched in brain endothelial cells in Sturge-Weber syndrome. Pediatr Neurol 2017; 67: 59-63
• 10 Didelot A, Le Corre D, Luscan A. , et al. Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples. Exp Mol Pathol 2012; 92 (03) 275-280
• 11 Applied Biosystems Product Bulletin. Accurate and sensitive somatic mutation detection powered by castPCR™ technology. Available at https://tools.thermofisher.com/content/sfs/brochures/cms_095916.pdf
• 12 Tan W, Nadora DM, Gao L, Wang G, Mihm Jr MC, Nelson JS. The somatic GNAQ mutation (R183Q) is primarily located within the blood vessels of port wine stains. J Am Acad Dermatol 2016; 74 (02) 380-383
• 13 Uchiyama Y, Nakashima M, Watanabe S. , et al. Ultra-sensitive droplet digital PCR for detecting a low-prevalence somatic GNAQ mutation in Sturge-Weber syndrome. Sci Rep 2016; 6: 22985
• 14 Roach ES. Neurocutaneous syndromes. Pediatr Clin North Am 1992; 39 (04) 591-620
• 15 Shirazi F, Cohen C, Fried L, Arbiser JL. Mammalian target of rapamycin (mTOR) is activated in cutaneous vascular malformations in vivo. Lymphat Res Biol 2007; 5 (04) 233-236
• 16 Di Trapani G, Di Rocco C, Abbamondi AL, Caldarelli M, Pocchiari M. Light microscopy and ultrastructural studies of Sturge-Weber disease. Childs Brain 1982; 9 (01) 23-36
• 17 McCartney E, Squier W. Patterns and pathways of calcification in the developing brain. Dev Med Child Neurol 2014; 56 (10) 1009-1015